Lannett Announces Pricing of Public Offering of Common Stock
2010年12月14日 - 11:30PM
ビジネスワイヤ(英語)
Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic
pharmaceuticals, today announced that it has priced an underwritten
public offering of an aggregate of 5,000,000 shares of its common
stock at a price to the public of $5.00 per share. The company has
offered 2,500,000 shares of common stock and a selling stockholder
of the company has offered 2,500,000 shares of common stock. The
offering is expected to close on or about December 17, 2010,
subject to customary closing conditions. Oppenheimer & Co. and
Roth Capital Partners are acting as co-book running managers, and
StoneGate Securities, Inc. and Emerging Growth Equities are acting
as co-managers for the offering. The company has also granted the
underwriters a 30-day option to purchase up to 750,000 shares to
cover over-allotments, if any.
The securities described above are being offered by Lannett and
the selling stockholder pursuant to a shelf registration statement
previously filed with and declared effective by the Securities and
Exchange Commission (SEC) on November 20, 2009. A prospectus
supplement related to the offering will be filed with the SEC and,
once filed, will be available on the SEC’s web site at
http://www.sec.gov. The prospectus supplement and accompanying
prospectus may be obtained by sending a request to Oppenheimer
& Co. Inc., Attention: Syndicate Prospectus Department, 300
Madison Avenue, 5th Floor, New York, NY, 10017, Telephone number:
(212) 667-8563, Email: EquityProspectus@opco.com. This press
release shall not constitute an offer to sell or the solicitation
of an offer to buy these securities, nor shall there be any sale of
these securities in any state or other jurisdiction in which such
offer, solicitation or sale would be unlawful prior to the
registration or qualification under the securities laws of any such
state or other jurisdiction.
About Lannett Company, Inc.:
Lannett Company, founded in 1942, develops, manufactures,
packages, markets and distributes generic pharmaceutical products
for a wide range of indications. For more information, visit
Lannett Company’s website at www.lannett.com.
This news release contains certain statements of a
forward-looking nature relating to future events or future business
performance. Any such statements, including, but not limited to,
Lannett’s expectations regarding the completion, timing and size of
its proposed public offering, whether expressed or implied, are
subject to risks and uncertainties which can cause actual results
to differ materially from those currently anticipated due to a
number of factors which include, but are not limited to, risks and
uncertainties associated with market conditions and the
satisfaction of customary closing conditions related to the
proposed offering, and other risk factors discussed in the
company’s Form 10-K and other documents filed with the Securities
and Exchange Commission from time to time. These forward-looking
statements represent the company's judgment as of the date of this
news release. The company disclaims any intent or obligation to
update these forward-looking statements.
London Clubs (AMEX:LCI)
過去 株価チャート
から 6 2024 まで 7 2024
London Clubs (AMEX:LCI)
過去 株価チャート
から 7 2023 まで 7 2024